Wright Medical Group NV (Wright Medical Group NV) Operating Income : $-11.5 Mil (TTM As of Sep. 2020)

View and export this data going back to 2011. Start your Free Trial

What is Wright Medical Group NV Operating Income?

Wright Medical Group NV's Operating Income for the three months ended in Sep. 2020 was $16.4 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2020 was $-11.5 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Wright Medical Group NV's Operating Income for the three months ended in Sep. 2020 was $16.4 Mil. Wright Medical Group NV's Revenue for the three months ended in Sep. 2020 was $223.4 Mil. Therefore, Wright Medical Group NV's Operating Margin % for the quarter that ended in Sep. 2020 was 7.32%.

Wright Medical Group NV's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Wright Medical Group NV's annualized ROC % for the quarter that ended in Sep. 2020 was 3.06%. Wright Medical Group NV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2020 was 5.59%.

Wright Medical Group NV Operating Income Historical Data

The historical data trend for Wright Medical Group NV's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wright Medical Group NV Operating Income Chart

Wright Medical Group NV Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Operating Income

Get a 7-Day Free Trial

-188.77

-122.96

-19.69

-7.80

11.59

Wright Medical Group NV Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Operating Income	Get a 7-Day Free Trial															-11.14	14.12	-2.69	-39.28	16.36

Wright Medical Group NV Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.5 Mil.

Wright Medical Group NV (NAS:WMGI) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Wright Medical Group NV's annualized ROC % for the quarter that ended in Sep. 2020 is calculated as:

	ROC % (Q: Sep. 2020 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2020 )	+	Invested Capital (Q: Sep. 2020 ))	/ count )
=	65.432 * ( 1 - -8.33% )	/	( (2310.761	+	2323.081)	/ 2 )
=	70.8824856	/	2316.921
=	3.06 %

where

	Invested Capital		(Q: Jun. 2020 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2563.527	-	406.878	-	( 133.651	-	max(0, 861.215	-	707.103	+	133.651	))
=	2310.761

	Invested Capital		(Q: Sep. 2020 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2598.719	-	420.587	-	( 141.549	-	max(0, 907.803	-	762.854	+	141.549	))
=	2323.081

Note: The Operating Income data used here is four times the quarterly (Sep. 2020) data.

2. Joel Greenblatt's definition of Return on Capital:

Wright Medical Group NV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2020 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2020 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2020		Q: Sep. 2020
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	24.784	/	( ( (259.313 + max(166.574, 0))	+	(260.73 + max(200.718, 0)) )	/	2 )
=	24.784	/	( ( 425.887	+	461.448 )	/	2 )
=	24.784	/	443.6675
=	5.59 %

where Working Capital is:

	Working Capital		(Q: Jun. 2020 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(107.701	+	238.783	+	226.968)	-	(406.878	+	0	+	1.1368683772162E-13)
=	166.574

	Working Capital		(Q: Sep. 2020 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(120.597	+	243.072	+	257.636)	-	(420.587	+	0	+	0)
=	200.718

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2020) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Wright Medical Group NV's Operating Margin % for the quarter that ended in Sep. 2020 is calculated as:

Operating Margin %	=	Operating Income (Q: Sep. 2020 )	/	Revenue (Q: Sep. 2020 )
	=	16.358	/	223.367
	=	7.32 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Wright Medical Group NV Operating Income Related Terms

Thank you for viewing the detailed overview of Wright Medical Group NV's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Wright Medical Group NV (Wright Medical Group NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group NV (NAS:WMGI) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB

Website

http://www.wright.com

Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sports medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.

Executives

Steven P. Wallace	officer: President, International	1023 CHERRY ROAD MEMPHIS TN 38117
Barry J. Regan	officer: SVP, Operations	1023 CHERRY ROAD, MEMPHIS TN 38117
Kevin C. Smith	officer: SVP, Quality and Regulatory	1023 CHERRY ROAD MEMPHIS TN 38117
Jason D. Asper	officer: SVP, Chief Digital Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Tim Lanier	officer: President, Upper Extremities	1023 CHERRY ROAD MEMPHIS TN 38117
Patrick Fisher	officer: President, Lower Extremities	1023 CHERRY ROAD MEMPHIS TN 38117
Jonathan Wesley Porter	officer: SVP, Chief Compliance Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Julie Andrews	officer: SVP, Global Finance	5677 AIRLINE ROAD, ARLINGTON TN 38002
Jennifer S. Walker	officer: SVP, Process Improvement	5677 AIRLINE ROAD ARLINGTON TN 38002
Andrew C. Morton	officer: SVP, Chief Human Resources Ofr	10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Lance A Berry	officer: EVP, Chief Finan./Op. Officer	5677 AIRLINE ROAD, ARLINGTON TN 38002
Julie D. Dewey	officer: SVP, Chief Comm. Officer	1023 CHERRY ROAD MEMPHIS TN 38117
Kevin D Cordell	officer: EVP, Chief Global Comm Officer	C/O WRIGHT MEDICAL GROUP, INC. 1023 CHERRY ROAD MEMPHIS TN 38117
Robert J Palmisano	director, officer: President and Chief Executive	110 HARTWELL AVENUE, LEXINGTON MA 02173
Peter Cooke	officer: Pres. Emerging Markets AUS/JAP	5677 AIRLINE ROAD ARLINGTON TN 38002